DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Personalized Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts" report to their offering.
Global Personalized Medicine Partnering 2010 to 2017 provides the full collection of Personalized Medicine disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Personalized Medicine disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Personalized Medicine deals.
Global Personalized Medicine Partnering 2010 to 2017 includes:
- Trends in Personalized Medicine dealmaking in the biopharma industry since 2010
- Analysis of Personalized Medicine deal structure
- Access to headline, upfront, milestone and royalty data
- Access to hundreds of Personalized Medicine deal contract documents
- Comprehensive access to over 3500 Personalized Medicine deal records
- The leading Personalized Medicine deals by value since 2010
Most active Personalized Medicine dealmakers since 2010
In Global Personalized Medicine Partnering 2010 to 2017, available deals and contracts are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Stage of development at signing
- Deal component type
- Technology type
- Specific therapy indication
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Personalized Medicine dealmaking
Chapter 3 -Financial deal terms for Personalized Medicine partnering
Chapter 4 - Leading Personalized Medicine deals and dealmakers
Chapter 5 - Personalized Medicine contract document directory
Chapter 6 - Personalized Medicine dealmaking by therapeutic target
For more information about this report visit http://www.researchandmarkets.com/research/fmjt38/global
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.